Pituitary papers

Cushing's syndrome

  • Dexamethasone-suppressed corticotrophin-releasing hormone-stimulation test does not reliably diagnose or predict recurrence of Cushing disease. Salem V, Dhillo WS, Meeran K, Donaldson M, Martin NM. Clin Chem. 2010 56(6):1031-4. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. J Clin Endocrinol Metab. 2008 93(5):1526-40.

  • The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Martin NM, Dhillo WS, Meeran K. Clin Endocrinol (Oxf). 2007 67(3):476.

  • Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome. Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, Todd JF, Meeran K. J Clin Endocrinol Metab. 2006 91(7):2582-6.

  • Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. J Clin Endocrinol Metab. 2008 93(7):2454-62.

Prolactinomas

  • Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia. Cabrita IZ, Hensman D, Grogono J, Dhillo WS, Baynes KC, Eliahoo J, Meeran K, Robinson S, Nihoyannopoulos P, Martin NM. Clin Endocrinol (Oxf). 2010 73(3):369-74.

  • Dopamine agonists and hyperprolactinaemia. BMJ. 2009 338:b381. Martin NM, Tan T, Meeran K.

    • High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.Banerjee A, Wynne K, Tan T, Hatfield EC, Martin NM, Williamson C, Meeran K. Clin Endocrinol (Oxf). 2009 70(5):812-3.

Acromegaly

  • The effects of long-term GH and IGF-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. CN Jayasena, AN Comninos, H Clarke, M Donaldson, K Meeran, WS Dhillo. Clin Endocrinol (Oxf). 2011. Epub ahead of print.

Management of pituitary tumours

  • Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors. Jayasena CN, Gadhvi KA, Gohel B, Martin NM, Mendoza N, Meeran K, Dhillo WS. Clin Chem. 2009 55(5):972-7.

    • A Case of Severe Hyponatraemia. Wynne K, Chaudhri OB, Gorrigan R, Tan T and Meeran K " BMJ November 2008;337:a2377